Alebund Pharmaceuticals
Clinical trials sponsored by Alebund Pharmaceuticals, explained in plain language.
-
New hope for dialysis patients: drug AP301 targets dangerous phosphate levels
Disease control Recruiting nowThis study tests a new drug called AP301 to see if it can safely lower high blood phosphate levels in people with kidney failure who are on dialysis. About 264 adults and teens will take either AP301 or a low-dose version for 8 weeks, then all receive AP301 for 24 weeks. The goal…
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
New pill for diabetic kidney disease enters early human testing
Disease control Recruiting nowThis early-stage study tests a new oral medication called AP303 in 18 adults with diabetic kidney disease. The main goals are to check the drug's safety and how the body handles it over two weeks. Participants will be randomly assigned to receive either AP303 or a placebo, and ne…
Phase: PHASE1 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:39 UTC